ACLARION INC (ACON)
US6551872012 - Common Stock
ACON gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 37 industry peers in the Health Care Technology industry. ACON has a bad profitability rating. Also its financial health evaluation is rather negative. ACON does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
ACON had negative earnings in the past year.
In the past year ACON has reported a negative cash flow from operations.
1.2 Ratios
The Return On Assets of ACON (-191.03%) is worse than 91.67% of its industry peers.
ACON has a worse Return On Equity (-359.30%) than 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -191.03% | ||
| ROE | -359.3% | ||
| ROIC | N/A |
ROA(3y)-257.22%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ACON does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ACON does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ACON has more shares outstanding
The debt/assets ratio for ACON is higher compared to a year ago.
2.2 Solvency
ACON has an Altman-Z score of -26.02. This is a bad value and indicates that ACON is not financially healthy and even has some risk of bankruptcy.
ACON has a worse Altman-Z score (-26.02) than 94.44% of its industry peers.
ACON has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
ACON has a worse Debt to Equity ratio (0.47) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -26.02 |
ROIC/WACCN/A
WACC10.44%
2.3 Liquidity
A Current Ratio of 1.28 indicates that ACON should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.28, ACON is in line with its industry, outperforming 41.67% of the companies in the same industry.
ACON has a Quick Ratio of 1.28. This is a normal value and indicates that ACON is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ACON (1.28) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 1.28 |
3. Growth
3.1 Past
ACON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 85.81%, which is quite impressive.
The Revenue for ACON has decreased by -35.17% in the past year. This is quite bad
ACON shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.77% yearly.
EPS 1Y (TTM)85.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.79%
Revenue 1Y (TTM)-35.17%
Revenue growth 3Y15.77%
Revenue growth 5YN/A
Sales Q2Q%-35.74%
3.2 Future
The Earnings Per Share is expected to decrease by -1.95% on average over the next years.
Based on estimates for the next years, ACON will show a very negative growth in Revenue. The Revenue will decrease by -27.54% on average per year.
EPS Next Y-114.47%
EPS Next 2Y-1.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-81.67%
Revenue Next 2Y-27.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ACON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ACON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.95%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ACON!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ACLARION INC
NASDAQ:ACON (12/20/2024, 8:00:00 PM)
After market: 0.127 +0 (+1.68%)0.1249
+0.01 (+8.99%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners3.28%
Inst Owner Change13.23%
Ins Owners10.11%
Ins Owner Change0%
Market Cap1.30M
Analysts82.5
Price Target1.27 (916.81%)
Short Float %3.84%
Short Ratio0.55
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.46%
Min EPS beat(2)22.6%
Max EPS beat(2)24.32%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-51.26%
Min Revenue beat(2)-56.98%
Max Revenue beat(2)-45.53%
Revenue beat(4)0
Avg Revenue beat(4)-67.13%
Min Revenue beat(4)-90.98%
Max Revenue beat(4)-45.53%
Revenue beat(8)2
Avg Revenue beat(8)-36.71%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)6.32%
EPS NY rev (3m)6.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-24.66%
Revenue NY rev (3m)-24.66%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 24.15 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.79 | ||
| P/tB | 3.21 | ||
| EV/EBITDA | N/A |
EPS(TTM)-4.73
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS0.01
BVpS0.16
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -191.03% | ||
| ROE | -359.3% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-257.22%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 117.61% | ||
| Cap/Sales | 378.52% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 1.28 | ||
| Altman-Z | -26.02 |
F-Score4
WACC10.44%
ROIC/WACCN/A
Cap/Depr(3y)91.21%
Cap/Depr(5y)N/A
Cap/Sales(3y)224.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.79%
EPS Next Y-114.47%
EPS Next 2Y-1.95%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.17%
Revenue growth 3Y15.77%
Revenue growth 5YN/A
Sales Q2Q%-35.74%
Revenue Next Year-81.67%
Revenue Next 2Y-27.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.31%
OCF growth 3YN/A
OCF growth 5YN/A